Cure8 trial brief
Why This Matters
This trial tests a non-drug way (virtual reality medical-hypnosis content) to reduce pain and embarrassment during rectosigmoidoscopy — a common, sometimes poorly tolerated procedure in ulcerative colitis that patients may need repeatedly.
Who Should Pay Attention
Adults with ulcerative colitis needing rectosigmoidoscopy; gastroenterologists and endoscopy teams; researchers studying non-pharmacologic procedural interventions.
Study Snapshot
What To Know
This is a completed randomized study registered at ClinicalTrials.gov (ACCEPT/ACCEPT follow-up context) enrolling about 100 adults with ulcerative colitis undergoing rectosigmoidoscopy. Participants were randomized to rectosigmoidoscopy with a VR headset versus the same procedure without a VR headset.
The primary outcome was pain measured by a visual analogue scale immediately after the examination. The trial was designed because prior surveys and a randomized trial in colonoscopy suggest VR can reduce procedural pain and anxiety.
This study focuses on rectosigmoidoscopy in UC where endoscopy remains important for mucosal assessment despite alternative tests (fecal calprotectin, ultrasound).
Keep In Mind
This is a ClinicalTrials.gov interventional trial record (completed) describing methods and outcomes to be measured; the registry text does not present study results. Prior smaller trials in colonoscopy suggested VR may reduce pain, but this record alone cannot confirm benefit for rectosigmoidoscopy.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.